Case 01: Esophageal Cancer
Treatment Performed
“Combined immunotherapy for cancer” was performed as treatment for residual metastasis from advanced esophageal cancer refractory to standard therapies, by combining the cancer vaccine therapy (one course) and a drug to inhibit immunosuppression.
Treatment Outcome
Prolonged inhibition of tumor growth
Before treatment
4 weeks after treatment initiation
7 weeks after treatment initiation
Before treatment
After treatment
The tumor marker turned to decrease
